Skip to content

Author

P. Aspinall

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial

Analysis of secondary outcomes suggests therapeutic promise, but rigorous evaluation in large-scale randomised controlled trials is essential to determine the true efficacy and clinical utility of intravenous remdesivir in people with Long COVID (LC).

M. Faghy, J. Chynoweth, A. Barnett et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.